Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Br J Anaesth ; 115(6): 896-902, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26582850

RESUMO

BACKGROUND: Early clot amplitudes measured on thromboelastometry (ROTEM®) predict maximum clot firmness (MCF) in adults. In this multicentre, retrospective study, we aimed to confirm the suspected relationship between early ROTEM® variables and MCF, in children undergoing cardiac or non-cardiac surgery. METHODS: 4762 ROTEM® tests (e.g. EXTEM, INTEM, FIBTEM, APTEM, and HEPTEM) performed in children undergoing cardiac or non-cardiac surgery at three University hospitals between January 2011 and June 2014 were reviewed. To assess the correlation between clot amplitudes measured after 5, 10 and 15 min and MCF, each variable was compared with the corresponding MCF by calculating Spearman's correlation coefficient. RESULTS: For the EXTEM® test, we observed that amplitude measured after 5 min (A5: r=0.91, P<0.001), 10 min (A10: r=0.95, P<0.001) and 15 min (A15: r=0.96, P<0.001) were strongly correlated to MCF. The same correlations were observed for INTEM® test (A5: r=0.93, P<0.001; A10: r=0.97, P<0.001; A15: r=0.97, P<0.001), and FIBTEM® test (A5: r=0.93, P<0.001; A10: r=0.94, P<0.001; A15: r=0.96, P<0.001). In addition, the amplitudes measured after five, 10 and 15 min were also strongly correlated with MCF in the APTEM® and the HEPTEM® tests. Receiver operating characteristics (ROC) analysis confirmed that A5, A10, A15 strongly predicted decreased MCF on all ROTEM® tests. CONCLUSIONS: This study confirmed that early values of clot amplitudes measured as soon as five, 10 or 15 min after clotting time could be used to predict maximum clot firmness in all ROTEM® tests.


Assuntos
Transtornos da Coagulação Sanguínea/diagnóstico , Cuidados Intraoperatórios/métodos , Tromboelastografia/métodos , Adolescente , Coagulação Sanguínea/fisiologia , Testes de Coagulação Sanguínea/métodos , Procedimentos Cirúrgicos Cardíacos , Criança , Pré-Escolar , Humanos , Lactente , Sistemas Automatizados de Assistência Junto ao Leito , Reprodutibilidade dos Testes , Estudos Retrospectivos , Fatores de Tempo
2.
Rev Esp Anestesiol Reanim (Engl Ed) ; 71(4): 282-290, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38408610

RESUMO

OBJECTIVE: To improve knowledge about routine clinical practice in the management of paediatric acute pain in Spain. METHODS: A telematic survey was conducted via the Internet on a representative sample of healthcare professionals involved in the management of paediatric acute pain (specifically anaesthesiologists) in Spain. The survey included 28 questions about their usual clinical practice in the assessment and treatment of acute pain, and also training and organisational aspects in paediatric acute pain. RESULTS: The survey was completed during March 2021 by 150 specialists in anaesthesiology. The respondents widely experienced in the management of acute paediatric pain (mean years of experience: 14.3: SD: 7.8), essentially in acute postoperative pain (97% of cases). Although 80% routinely used validated paediatric acute pain assessment scales, only 2.6% used specific scales adapted for patients with cognitive impairment. Most of the respondents routinely used analgesic drugs such as paracetamol (99%) or metamizole (92%), but only 84% complemented these drugs with a loco-regional blocking technique or other non-steroidal anti-inflammatory drugs (62%). Furthermore, only 62.7% acknowledged having received specific training in paediatric acute pain, only 45% followed hospital institutional protocols, and a scant 28% did so through paediatric pain units. CONCLUSIONS: The survey identified important points for improvement in the training and organisation of acute pain management in Spanish paediatric patients.


Assuntos
Dor Aguda , Pesquisas sobre Atenção à Saúde , Manejo da Dor , Espanha , Humanos , Dor Aguda/tratamento farmacológico , Dor Aguda/terapia , Manejo da Dor/métodos , Criança , Padrões de Prática Médica/estatística & dados numéricos , Pediatria , Dor Pós-Operatória/tratamento farmacológico , Dor Pós-Operatória/terapia , Analgésicos/uso terapêutico , Medição da Dor/estatística & dados numéricos , Anestesiologia/educação , Anestesiologistas/estatística & dados numéricos
3.
Rev Esp Anestesiol Reanim ; 59(9): 489-96, 2012 Nov.
Artigo em Espanhol | MEDLINE | ID: mdl-22980396

RESUMO

OBJECTIVES: To describe the use of levosimendan for compassionate use in children undergoing surgery for congenital heart disease, as well as survival rates, and the variations in the haemodynamic and analytical variables studied. MATERIAL AND METHODS: An observational retrospective descriptive study was performed, using a review of clinical histories, from May 2005 to January 2010. Haemodynamic and analytical variables pre- and post- levosimendan administration, drugs used, and their dosages, and any adverse reactions were recorded. RESULTS: Forty two children, 38 of them undergoing surgical correction, between the ages of four days and 5.75 years (median 92 days) were included. The drug was infused on 46 occasions. Four children received two doses. The infusion rate was among 0.1 to 0.6 µg × kg⁻¹ × min⁻¹. Only one patient received a loading dose. In 15 administrations (32.6%), the same dose was maintained throughout the infusion period. In 19 cases (41.3%), the dose was increased or decreased according to the need for vasoactive support. In surgical patients, overall survival after 30 days of the administration, calculated using the Kaplan-Meier method, was 80%. Blood lactate levels were statistically associated with mortality (P<.001). CONCLUSIONS: There were no uniform criteria for using levosimendan, and it was only used as a rescue drug. Overall survival was similar to that reported in adult clinical trials. Clinical trials also need to be carried out in paediatric patients to determine the role of levosimendan in surgical practice, in order to develop and establish a clinical protocol for its use in children.


Assuntos
Cardiotônicos/uso terapêutico , Cardiopatias Congênitas/cirurgia , Hidrazonas/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Piridazinas/uso terapêutico , Cardiotônicos/administração & dosagem , Cardiotônicos/efeitos adversos , Cardiotônicos/farmacologia , Pré-Escolar , Comorbidade , Ensaios de Uso Compassivo , Circulação Coronária/efeitos dos fármacos , Síndrome de Down/complicações , Avaliação de Medicamentos , Feminino , Cardiopatias Congênitas/mortalidade , Hemodinâmica/efeitos dos fármacos , Humanos , Hidrazonas/administração & dosagem , Hidrazonas/efeitos adversos , Hidrazonas/farmacologia , Hipotensão/induzido quimicamente , Lactente , Recém-Nascido , Estimativa de Kaplan-Meier , Masculino , Isquemia Miocárdica/prevenção & controle , Complicações Pós-Operatórias/mortalidade , Canais de Potássio/efeitos dos fármacos , Piridazinas/administração & dosagem , Piridazinas/efeitos adversos , Piridazinas/farmacologia , Estudos Retrospectivos , Terapia de Salvação , Simendana , Taquicardia/induzido quimicamente
6.
Rev Esp Anestesiol Reanim ; 36(3): 140-4, 1989.
Artigo em Espanhol | MEDLINE | ID: mdl-2762607

RESUMO

The effect of halothane, enflurane and isoflurane (at concentrations ranging from 0.1 v/v% to 5 v/v%) on ventricular automaticity induced by a local injury, has been studied in the isolated right ventricle of the rat. Both, halothane and isoflurane, effectively reduces ventricular frequency at all concentrations tested. On the contrary, enflurane (0.3, 0.5 and 1 v/v%) increases ventricular automaticity. The effect of enflurane was either potentiated or reduced respectively in the presence of lower or higher calcium concentrations.


Assuntos
Enflurano/farmacologia , Halotano/farmacologia , Isoflurano/farmacologia , Contração Miocárdica/efeitos dos fármacos , Anestesia por Inalação , Animais , Cálcio/fisiologia , Feminino , Masculino , Ratos , Ratos Endogâmicos
7.
Rev Esp Anestesiol Reanim ; 44(4): 135-9, 1997 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-9244939

RESUMO

OBJECTIVES: To compare the analgesic efficacy and repercussion on labor of early administration of two different concentrations of bupivacaine/fentanyl in continuous epidural perfusion, in comparison with a control group receiving no epidural anesthesia. PATIENTS AND METHODS: One hundred fifty patients were distributed among 3 groups. Group I (n = 50) received no epidural analgesia. Group II (n = 50) and III (n = 50) received test doses of 3 ml of bupivacaine plus adrenalin 1/200,000. After 5 minutes each patient in the study groups received 13 ml of the solution assigned (group II: 0.04% bupivacaine plus adrenalin 1/2,500,000 and fentanyl 2.5 micrograms/ml; group III: 0.0625% bupivacaine plus adrenalin 1/1,600,000 and fentanyl 2 micrograms/ml). Five minutes later a perfusion of 12 ml/h-1 of the same solution was delivered until dilation was complete. RESULTS: Epidural perfusion was started at 2.5 +/- 0.93 cm of dilation (group II) and 2.3 +/- 0.92 cm (group III). There were no statistically significant differences in either duration of labor until full dilation or expulsion among the groups. Pain assessed on a visual analog scale evolved from a baseline mean of 4.5 to 5 in the three groups, reaching 8.9 +/- 0.74 (group I), 0.24 +/- 0.89 (group II) and 0.28 +/- 0.57 (group III). There were no significant differences in fetal presentation or Apgar scores among the three groups at the end of delivery. CONCLUSION: Both solutions provide good analgesia during labor with minimum undesirable side effects. Low epidural doses of bupivacaine and fentanyl started early do not affect the course of labor.


Assuntos
Analgesia Epidural , Analgesia Obstétrica , Analgésicos Opioides/uso terapêutico , Anestésicos Locais/uso terapêutico , Bupivacaína/uso terapêutico , Fentanila/uso terapêutico , Trabalho de Parto/efeitos dos fármacos , Analgesia Epidural/efeitos adversos , Analgesia Obstétrica/efeitos adversos , Analgésicos Opioides/administração & dosagem , Analgésicos Opioides/efeitos adversos , Anestésicos Locais/administração & dosagem , Anestésicos Locais/efeitos adversos , Bupivacaína/administração & dosagem , Bupivacaína/efeitos adversos , Feminino , Fentanila/administração & dosagem , Fentanila/efeitos adversos , Humanos , Recém-Nascido , Perfusão , Gravidez
8.
Cir Pediatr ; 16(1): 30-3, 2003 Jan.
Artigo em Espanhol | MEDLINE | ID: mdl-12793291

RESUMO

AIM: To evaluate the efficiency in the control of the post-surgical paediatric pain of the combination of a weak opioid [tramadol (T)] and an NSAID (paracetamol), comparing its administration through "Nursing-PCA" (NCA) techniques or through continuous i.v. infusion. METHODS: The investigation has been carried out in 30 patients (mean 9.5 months) selected according to their foreseeable degree of moderate-hard pain. All of them consumed in the postoperative period: rectal paracetamol (20 mg/Kg) every 8 hours and tramadol in two groups. Group I: PCA pump with tramadol that was handled by the nurse. Initial dose: 0.5 mg/Kg NCA, bolus injection 0.3 mg/Kg with an interval of 10 minutes for security and a highest dose of 1.2 mg/Kg/4 h every 4 hours. Group II: continuous infusion i.v. of tramadol (6 mg/Kg/24 h). The pain was evaluated, as well as the sedative action, saturation oxygen, respiratory and hemodynamics parameters, adverse effects, and efficiency during the first 24 hours, as well as the number of total dose of drugs asked in the Nursing PCA group. RESULTS: Pain decreased in both groups. There were more sedative effects in group II and the total dose of tramadol was higher. There were no cases of respiratory depression. CONCLUSIONS: The combination of tramadol and paracetamol through "Nursing PCA" has turned out to be an efficient method in the treatment of the post-surgical pain in little children and those whose are in their lacteal period. It is a possible alternative of the continuous infusion of Morphine in these patients.


Assuntos
Analgesia Controlada pelo Paciente/métodos , Analgésicos Opioides/uso terapêutico , Dor Pós-Operatória/tratamento farmacológico , Tramadol/uso terapêutico , Feminino , Humanos , Lactente , Recém-Nascido , Injeções Intravenosas , Masculino , Medição da Dor , Cuidados Pós-Operatórios/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA